Small cell carcinoma of the lung differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
(16 intermediate revisions by 8 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | [[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Small_cell_lung_cancer]] | ||
{{CMG}}: {{AE}} {{EG}} | |||
==Overview== | |||
Depending on the presentation, [[lung cancer]] should be differentiated from other lung diseases such as [[pulmonary tuberculosis]], lung [[abscess]], and [[respiratory tract]] infection and [[autoimmune]] diseases affecting the [[respiratory tract]]. Once [[lung cancer]] is confirmed, small cell carcinoma should be differentiated from other [[NSCLC|non-small cell carcinoma]] based on histopathological findings. | |||
{{ | ==Differentiating Small Cell Lung Cancer from other Diseases== | ||
== | Small cell lung cancer should be differentiated from other diseases causing [[cough]], [[hemoptysis]], and [[weight loss]]. The following are the differentials:<ref name="pmid24455507">{{cite journal| author=Bhatt M, Kant S, Bhaskar R| title=Pulmonary tuberculosis as differential diagnosis of lung cancer. | journal=South Asian J Cancer | year= 2012 | volume= 1 | issue= 1 | pages= 36-42 | pmid=24455507 | doi=10.4103/2278-330X.96507 | pmc=PMC3876596 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24455507 }} </ref> | ||
== | {| | ||
:*[[Chronic | ! colspan="2" rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Organ System | ||
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease | |||
! colspan="8" align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical Manifestations | |||
! colspan="4" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Diagnosis | |||
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Other Features | |||
|- | |||
! colspan="7" align="center" style="background:#4479BA; color: #FFFFFF;" + |Symptoms | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Physical Exam | |||
|- | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Onset | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Duration | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Productive Cough | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hemoptysis | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Weight Loss | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Fever | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Dyspnea | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ascultation | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Lab Findings | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Imaging | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Pulmonary Function Test | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold Standard | |||
|- | |||
| rowspan="3" align="center" style="background:#DCDCDC;" + |[[Respiratory system|'''Respiratory''']] | |||
| rowspan="3" align="center" style="background:#DCDCDC;" + |[[Parenchyma|'''Parenchyma''']] | |||
| align="center" style="background:#DCDCDC;" + |[[Lung cancer|'''Lung cancer''']]<ref name="pmid21296855">{{cite journal |vauthors=Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D |title=Global cancer statistics |journal=CA Cancer J Clin |volume=61 |issue=2 |pages=69–90 |year=2011 |pmid=21296855 |doi=10.3322/caac.20107 |url=}}</ref><ref name="pmid23649435">{{cite journal |vauthors=Ost DE, Jim Yeung SC, Tanoue LT, Gould MK |title=Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines |journal=Chest |volume=143 |issue=5 Suppl |pages=e121S–e141S |year=2013 |pmid=23649435 |pmc=4694609 |doi=10.1378/chest.12-2352 |url=}}</ref> | |||
| align="center" style="background:#F5F5F5;" + |Chronic | |||
| style="background:#F5F5F5;" + | | |||
*Years | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | +/− | |||
! align="center" style="background:#F5F5F5;" + | + | |||
| style="background:#F5F5F5;" + | | |||
*[[Hoarseness]] | |||
| style="background:#F5F5F5;" + |The following investigations may be helpful: | |||
*[[Complete blood count]] ([[Complete blood count|CBC]]) | |||
*[[Alanine transaminase|ALT]], [[Aspartate transaminase|AST]] | |||
*[[Calcium]] | |||
*[[Alkaline phosphatase]] | |||
*[[Lactate dehydrogenase|LDH]] | |||
*[[Creatinine]] | |||
| style="background:#F5F5F5;" + | | |||
*[[Contrast enhanced CT|Contrast−enhanced CT]] of chest and upper abdomen | |||
| style="background:#F5F5F5;" + | | |||
*Not specific | |||
| style="background:#F5F5F5;" + | | |||
*Tissue [[biopsy]] (sample should be sufficient for [[Molecule|molecular]] testing) | |||
| style="background:#F5F5F5;" + | | |||
*Risk factor: | |||
**Cigarette smoking | |||
*Types | |||
**[[Small cell lung cancer|Small cell lung cance]]<nowiki/>r ([[Small cell lung cancer|SCLC]]) | |||
**[[Non small cell lung cancer|Non−small cell lung cance]]<nowiki/>r ([[Non small cell lung cancer|NSCLC]]) | |||
|- | |||
| align="center" style="background:#DCDCDC;" + |'''[[Interstitial lung disease]]'''<ref name="pmid15331185">{{cite journal |vauthors=Lama VN, Martinez FJ |title=Resting and exercise physiology in interstitial lung diseases |journal=Clin. Chest Med. |volume=25 |issue=3 |pages=435–53, v |year=2004 |pmid=15331185 |doi=10.1016/j.ccm.2004.05.005 |url=}}</ref><ref name="pmid15133338">{{cite journal |vauthors=Chetta A, Marangio E, Olivieri D |title=Pulmonary function testing in interstitial lung diseases |journal=Respiration |volume=71 |issue=3 |pages=209–13 |year=2004 |pmid=15133338 |doi=10.1159/000077416 |url=}}</ref> | |||
| align="center" style="background:#F5F5F5;" + |Chronic | |||
| style="background:#F5F5F5;" + | | |||
*Variable | |||
! align="center" style="background:#F5F5F5;" + |− | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + |− | |||
! align="center" style="background:#F5F5F5;" + | + | |||
| style="background:#F5F5F5;" + | | |||
*[[Wheeze|Wheezing]] | |||
*[[Rales|Crackles]] or velcro rales | |||
*[[Lung volumes|Inspiratory]] high−pitched [[rhonchi]] | |||
| style="background:#F5F5F5;" + |The following investigations may be helpful: | |||
*[[Hepatic function test]] | |||
*[[Renal function tests|Renal function test]] | |||
*[[Complete blood count|CBC]] | |||
*[[Serology|Serological testing]] | |||
| style="background:#F5F5F5;" + | | |||
*[[Nodular]], [[reticular]] or both pattern in [[Chest X-ray|chest X−ray]] | |||
*[[Computed tomography|CT]] in patients with diffuse pulmonary lung disease | |||
| style="background:#F5F5F5;" + | | |||
*Reduction in [[Vital capacity|FVC]], [[Residual volume|RV]], [[Functional residual capacity|FRC]], [[Total lung capacity|TLC]] and [[FEV1]] on spirometry | |||
*[[FEV1/FVC ratio|FEV1/FVC]] normal or increase | |||
*[[Lung volumes]] | |||
*Diffusion capacity ([[DLCO]] reduced) | |||
| style="background:#F5F5F5;" + | | |||
*Lung [[biopsy]] when lab, imaging, and PFT has indeterminate result | |||
| style="background:#F5F5F5;" + | | |||
*Clubbing is common in [[asbestosis]] and [[idiopathic pulmonary fibrosis]] | |||
|- | |||
| align="center" style="background:#DCDCDC;" + |'''[[Tuberculosis]] ([[Tuberculosis|TB]])'''<ref name="pmid9332519">{{cite journal |vauthors=Perlman DC, el-Sadr WM, Nelson ET, Matts JP, Telzak EE, Salomon N, Chirgwin K, Hafner R |title=Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG) |journal=Clin. Infect. Dis. |volume=25 |issue=2 |pages=242–6 |year=1997 |pmid=9332519 |doi= |url=}}</ref><ref name="pmid2456183">{{cite journal |vauthors=Barnes PF, Verdegem TD, Vachon LA, Leedom JM, Overturf GD |title=Chest roentgenogram in pulmonary tuberculosis. New data on an old test |journal=Chest |volume=94 |issue=2 |pages=316–20 |year=1988 |pmid=2456183 |doi= |url=}}</ref> | |||
| align="center" style="background:#F5F5F5;" + |Chronic | |||
| style="background:#F5F5F5;" + | | |||
*More than 2 or 3 weeks | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | + | |||
| style="background:#F5F5F5;" + | | |||
*[[Pleural effusion]] | |||
*[[Crackles]] | |||
*[[Whispered pectoriloquy]] | |||
*Decreased fremitus | |||
*[[Rhonchi]] | |||
| style="background:#F5F5F5;" + | | |||
*Sputum [[Acid-fast|acid−fast]] bacilli ([[Acid-fast|AFB]]) smear may be positive | |||
*[[Mycobacterium|Mycobacterial]] [[Culture media|culture]] may be positive | |||
*Molecular testing may be helpful | |||
| style="background:#F5F5F5;" + | | |||
*Reactivation of [[Tuberculosis|TB]] is observed as [[Infiltration (medical)|infiltration]] in the upper [[Lobe (anatomy)|lobe]] in [[Chest X-ray|chest X−Ray]] | |||
*In patients with [[Human Immunodeficiency Virus (HIV)|HIV]], Tb is observed as lobar [[Infiltration (medical)|infiltration]], [[adenopathy]], lung mass named [[tuberculoma]], small fibronodular lesions, and/or [[pleural effusion]] on [[Chest X-ray|chest X−Ray]] | |||
*[[Computed tomography|CT]] can detect early nodal process | |||
| style="background:#F5F5F5;" + | | |||
*Decreased [[FEV1]] | |||
*Reduced [[Vital capacity|FVC]] | |||
| style="background:#F5F5F5;" + | | |||
*Isolation of ''[[Mycobacterium tuberculosis]]'' from some [[secretion]] | |||
| style="background:#F5F5F5;" + | | |||
*Etiology: ''[[Mycobacterium tuberculosis]]'' | |||
*Complications: [[Pneumothorax]], [[bronchiectasis]], pulmonary destruction and [[chronic pulmonary aspergillosis]] | |||
|- | |||
| colspan="2" align="center" style="background:#DCDCDC;" + |[[Heart|'''Cardiac''']] | |||
| align="center" style="background:#DCDCDC;" + |[[Pulmonary hypertension|'''Pulmonary hypertension''']]<ref name="pmid21393391">{{cite journal |vauthors=Brown LM, Chen H, Halpern S, Taichman D, McGoon MD, Farber HW, Frost AE, Liou TG, Turner M, Feldkircher K, Miller DP, Elliott CG |title=Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry |journal=Chest |volume=140 |issue=1 |pages=19–26 |year=2011 |pmid=21393391 |pmc=3198486 |doi=10.1378/chest.10-1166 |url=}}</ref><ref name="pmid12651053">{{cite journal| author=Sun XG, Hansen JE, Oudiz RJ, Wasserman K| title=Pulmonary function in primary pulmonary hypertension. | journal=J Am Coll Cardiol | year= 2003 | volume= 41 | issue= 6 | pages= 1028-35 | pmid=12651053 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12651053 }}</ref> | |||
| align="center" style="background:#F5F5F5;" + |Chronic | |||
| style="background:#F5F5F5;" + | | |||
*More than 2 years | |||
! align="center" style="background:#F5F5F5;" + |− | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + |− | |||
! align="center" style="background:#F5F5F5;" + | + | |||
| style="background:#F5F5F5;" + | | |||
*[[Dysphonia|Hoarseness]] | |||
| style="background:#F5F5F5;" + |The following investigations may be helpful: | |||
*[[Human Immunodeficiency Virus (HIV)|HIV]] serology | |||
*[[Anti-nuclear antibody|Antinuclear antibody]] ([[Antinuclear antibodies|ANA]]) | |||
*[[Rheumatoid factor]] ([[RF]]) | |||
*[[Anti-neutrophil cytoplasmic antibody|Anti−neutrophil cytoplasmic antibody]] ([[Anti-neutrophil cytoplasmic antibody|ANCA]]) | |||
| style="background:#F5F5F5;" + | | |||
*Enlargement of the central [[pulmonary artery]] and right heart in [[Chest X-ray|chest X−Ray]] | |||
*[[Pulmonary artery]] systolic pressure can be estimated in [[echocardiography]] | |||
| style="background:#F5F5F5;" + | | |||
*Low levels of [[FEV1]] | |||
*Decreased [[Vital capacity|FVC]] | |||
*[[DLCO]] reduced | |||
| style="background:#F5F5F5;" + | | |||
*Mean [[pulmonary artery]] pressure more than 25 [[mmHg]] at rest | |||
| style="background:#F5F5F5;" + | | |||
*[[Chest pain]] | |||
*[[Ascites]] | |||
*[[Syncope]] | |||
*Peripherial [[edema]] | |||
|- | |||
! colspan="2" rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Organ system | |||
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Diseases | |||
! colspan="8" align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical manifestations | |||
! colspan="4" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Diagnosis | |||
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Other features | |||
|- | |||
! colspan="7" align="center" style="background:#4479BA; color: #FFFFFF;" + |Symptoms | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Physical exam | |||
|- | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Onset | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Duration | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Productive cough | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Hemoptysis | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Weight lost | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Fever | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Dyspnea | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Ascultation | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Lab findings | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Imaging | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |PFT | |||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold standard | |||
|- | |||
| colspan="2" rowspan="3" align="center" style="background:#DCDCDC;" + |'''[[Autoimmune]]''' | |||
| align="center" style="background:#DCDCDC;" + |[[Granulomatosis with polyangiitis|'''Wegener's disease''']] ([[Granulomatosis with polyangiitis|'''GPA''']]) <ref name="pmid1739240">{{cite journal |vauthors=Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS |title=Wegener granulomatosis: an analysis of 158 patients |journal=Ann. Intern. Med. |volume=116 |issue=6 |pages=488–98 |year=1992 |pmid=1739240 |doi= |url=}}</ref><ref name="pmid21374588">{{cite journal |vauthors=Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DR, Jennette JC, Kallenberg CG, Luqmani R, Mahr AD, Matteson EL, Merkel PA, Specks U, Watts RA |title=Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis |journal=Arthritis Rheum. |volume=63 |issue=4 |pages=863–4 |year=2011 |pmid=21374588 |doi=10.1002/art.30286 |url=}}</ref> | |||
| align="center" style="background:#F5F5F5;" + |Chronic | |||
| style="background:#F5F5F5;" + | | |||
*Months | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | + | |||
| style="background:#F5F5F5;" + | | |||
*[[Hoarseness]] | |||
*[[Stridor]] | |||
*[[Wheeze|Wheezing]] | |||
| style="background:#F5F5F5;" + |The following investigations may be helpful: | |||
*[[Anti-neutrophil cytoplasmic antibody|ANCA]], [[P-ANCA|P−ANCA]], [[C-ANCA|C−ANCA]] | |||
*[[Blood urea nitrogen|BUN]] | |||
*[[Creatinine]] | |||
*[[Complete blood count]] | |||
*[[Urinalysis]] | |||
*Lung [[biopsy]] | |||
| style="background:#F5F5F5;" + | | |||
*[[Nodules]], [[Lung|pulmonary]] infiltrates, reticular margins, pleural opacities and [[Cavity|cavities]] in [[Chest X-ray|chest X−Ray]] | |||
*[[Nodule (medicine)|Nodules]], [[cavities]] and stellate−shaped peripherial [[pulmonary]] in chest [[Computed tomography|CT]] | |||
*[[Bronchoscopy]] may be helpful | |||
| style="background:#F5F5F5;" + | | |||
*Low levels of [[DLCO]] | |||
*Reduce [[lung volumes]] | |||
| style="background:#F5F5F5;" + | | |||
*Tissue [[biopsy]] | |||
| style="background:#F5F5F5;" + | | |||
*Nasal crusting, sinus pain, chronic [[rhinosinusitis]], nasal obstruction and discharge in [[Upper respiratory tract|upper airway]] | |||
*[[Saddle nose|Saddle nose deformity]] | |||
*[[Purpura]] in lower extremities | |||
|- | |||
| align="center" style="background:#DCDCDC;" + |'''Microscopic polyangitis ([[Microscopic polyangiitis|MPA]])'''<ref name="JennetteFalk1997">{{cite journal|last1=Jennette|first1=J. Charles|last2=Falk|first2=Ronald J.|title=Small-Vessel Vasculitis|journal=New England Journal of Medicine|volume=337|issue=21|year=1997|pages=1512–1523|issn=0028-4793|doi=10.1056/NEJM199711203372106}}</ref> | |||
| align="center" style="background:#F5F5F5;" + |Chronic | |||
| style="background:#F5F5F5;" + | | |||
*Variable | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | + | |||
| style="background:#F5F5F5;" + | | |||
*[[Hoarseness]] | |||
*[[Stridor]] | |||
*[[Wheeze|Wheezing]] | |||
| style="background:#F5F5F5;" + |The following investigations may be helpful: | |||
*[[ANCA]] positive | |||
*[[Blood urea nitrogen|BUN]] | |||
*[[Creatinine]] | |||
*[[Complete blood count]] | |||
*[[Urinalysis]] | |||
| style="background:#F5F5F5;" + | | |||
*[[Cavitation]], [[Nodule (medicine)|nodules]], and alveolar opacities in [[Chest X-ray|chest X−ray]] | |||
*Head and chest [[Computed tomography|CT]] may be helpful | |||
*[[Electromyography]]/[[nerve conduction study]] may also be helpful | |||
| style="background:#F5F5F5;" + | | |||
*Reduced [[lung volumes]] | |||
| style="background:#F5F5F5;" + | | |||
*Tissue [[biopsy]] | |||
| style="background:#F5F5F5;" + | | |||
*[[Nerve]] damage | |||
*[[Rhinosinusitis]] | |||
*[[Purpura]] involving lower extremities | |||
|- | |||
| align="center" style="background:#DCDCDC;" + |[[Eosinophilic granulomatosis with polyangiitis|'''Churg−Strauss''']]<ref name="pmid23330816">{{cite journal |vauthors=Vaglio A, Buzio C, Zwerina J |title=Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art |journal=Allergy |volume=68 |issue=3 |pages=261–73 |year=2013 |pmid=23330816 |doi=10.1111/all.12088 |url=}}</ref><ref name="pmid6366453">{{cite journal |vauthors=Lanham JG, Elkon KB, Pusey CD, Hughes GR |title=Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome |journal=Medicine (Baltimore) |volume=63 |issue=2 |pages=65–81 |year=1984 |pmid=6366453 |doi= |url=}}</ref> | |||
| align="center" style="background:#F5F5F5;" + |Chronic | |||
| style="background:#F5F5F5;" + | | |||
*Variable | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | + | |||
! align="center" style="background:#F5F5F5;" + | + | |||
| style="background:#F5F5F5;" + | | |||
*[[Wheeze|Wheezing]] | |||
*[[Rales]] | |||
*[[Rhonchi]] | |||
*Expiratory sounds(related to [[asthma]]) | |||
| style="background:#F5F5F5;" + | | |||
*Peripherial [[eosinophilia]] | |||
*In active phase [[C-reactive protein|CRP]] and [[Red blood cell|erytrocyte]] [[sedimentation]] rate high | |||
*Elevated [[Immunoglobulin E|IgE]] | |||
*[[Anti-neutrophil cytoplasmic antibody|ANCA]] positive | |||
| style="background:#F5F5F5;" + | | |||
*Infiltrates in [[Chest X-ray|chest X−Ray]] | |||
*Ground glass opacities, tree−in−bud sign and small nodules in chest [[Computed tomography|CT]] | |||
| style="background:#F5F5F5;" + | | |||
*[[Lung volumes]] decreased | |||
*[[Vital capacity|FVC]] reduced | |||
*[[FEV1/FVC ratio]] <70% | |||
| style="background:#F5F5F5;" + | | |||
*Tissue [[biopsy]] | |||
| style="background:#F5F5F5;" + | | |||
*[[Asthma]] | |||
*[[Eosinophilia]] | |||
*[[Rhinosinusitis]] | |||
|} | |||
==References== | |||
{{Reflist|2}} | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category: | [[Category:Types of cancer]] | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
[[Category: | [[Category:Lung cancer]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Pulmonology]] | |||
[[Category:Surgery]] |
Latest revision as of 22:02, 3 September 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]: Associate Editor(s)-in-Chief: Eiman Ghaffarpasand, M.D. [2]
Overview
Depending on the presentation, lung cancer should be differentiated from other lung diseases such as pulmonary tuberculosis, lung abscess, and respiratory tract infection and autoimmune diseases affecting the respiratory tract. Once lung cancer is confirmed, small cell carcinoma should be differentiated from other non-small cell carcinoma based on histopathological findings.
Differentiating Small Cell Lung Cancer from other Diseases
Small cell lung cancer should be differentiated from other diseases causing cough, hemoptysis, and weight loss. The following are the differentials:[1]
Organ System | Disease | Clinical Manifestations | Diagnosis | Other Features | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical Exam | ||||||||||||||
Onset | Duration | Productive Cough | Hemoptysis | Weight Loss | Fever | Dyspnea | Ascultation | Lab Findings | Imaging | Pulmonary Function Test | Gold Standard | ||||
Respiratory | Parenchyma | Lung cancer[2][3] | Chronic |
|
+ | + | + | +/− | + | The following investigations may be helpful: |
|
|
| ||
Interstitial lung disease[4][5] | Chronic |
|
− | + | + | − | + |
|
The following investigations may be helpful: |
|
|
| |||
Tuberculosis (TB)[6][7] | Chronic |
|
+ | + | + | + | + |
|
|
|
|
| |||
Cardiac | Pulmonary hypertension[8][9] | Chronic |
|
− | + | + | − | + | The following investigations may be helpful: |
|
|
| |||
Organ system | Diseases | Clinical manifestations | Diagnosis | Other features | |||||||||||
Symptoms | Physical exam | ||||||||||||||
Onset | Duration | Productive cough | Hemoptysis | Weight lost | Fever | Dyspnea | Ascultation | Lab findings | Imaging | PFT | Gold standard | ||||
Autoimmune | Wegener's disease (GPA) [10][11] | Chronic |
|
+ | + | + | + | + | The following investigations may be helpful: |
|
|
|
| ||
Microscopic polyangitis (MPA)[12] | Chronic |
|
+ | + | + | + | + | The following investigations may be helpful:
|
|
|
|
| |||
Churg−Strauss[13][14] | Chronic |
|
+ | + | + | + | + |
|
|
|
|
References
- ↑ Bhatt M, Kant S, Bhaskar R (2012). "Pulmonary tuberculosis as differential diagnosis of lung cancer". South Asian J Cancer. 1 (1): 36–42. doi:10.4103/2278-330X.96507. PMC 3876596. PMID 24455507.
- ↑ Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011). "Global cancer statistics". CA Cancer J Clin. 61 (2): 69–90. doi:10.3322/caac.20107. PMID 21296855.
- ↑ Ost DE, Jim Yeung SC, Tanoue LT, Gould MK (2013). "Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines". Chest. 143 (5 Suppl): e121S–e141S. doi:10.1378/chest.12-2352. PMC 4694609. PMID 23649435.
- ↑ Lama VN, Martinez FJ (2004). "Resting and exercise physiology in interstitial lung diseases". Clin. Chest Med. 25 (3): 435–53, v. doi:10.1016/j.ccm.2004.05.005. PMID 15331185.
- ↑ Chetta A, Marangio E, Olivieri D (2004). "Pulmonary function testing in interstitial lung diseases". Respiration. 71 (3): 209–13. doi:10.1159/000077416. PMID 15133338.
- ↑ Perlman DC, el-Sadr WM, Nelson ET, Matts JP, Telzak EE, Salomon N, Chirgwin K, Hafner R (1997). "Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG)". Clin. Infect. Dis. 25 (2): 242–6. PMID 9332519.
- ↑ Barnes PF, Verdegem TD, Vachon LA, Leedom JM, Overturf GD (1988). "Chest roentgenogram in pulmonary tuberculosis. New data on an old test". Chest. 94 (2): 316–20. PMID 2456183.
- ↑ Brown LM, Chen H, Halpern S, Taichman D, McGoon MD, Farber HW, Frost AE, Liou TG, Turner M, Feldkircher K, Miller DP, Elliott CG (2011). "Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry". Chest. 140 (1): 19–26. doi:10.1378/chest.10-1166. PMC 3198486. PMID 21393391.
- ↑ Sun XG, Hansen JE, Oudiz RJ, Wasserman K (2003). "Pulmonary function in primary pulmonary hypertension". J Am Coll Cardiol. 41 (6): 1028–35. PMID 12651053.
- ↑ Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS (1992). "Wegener granulomatosis: an analysis of 158 patients". Ann. Intern. Med. 116 (6): 488–98. PMID 1739240.
- ↑ Falk RJ, Gross WL, Guillevin L, Hoffman GS, Jayne DR, Jennette JC, Kallenberg CG, Luqmani R, Mahr AD, Matteson EL, Merkel PA, Specks U, Watts RA (2011). "Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis". Arthritis Rheum. 63 (4): 863–4. doi:10.1002/art.30286. PMID 21374588.
- ↑ Jennette, J. Charles; Falk, Ronald J. (1997). "Small-Vessel Vasculitis". New England Journal of Medicine. 337 (21): 1512–1523. doi:10.1056/NEJM199711203372106. ISSN 0028-4793.
- ↑ Vaglio A, Buzio C, Zwerina J (2013). "Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art". Allergy. 68 (3): 261–73. doi:10.1111/all.12088. PMID 23330816.
- ↑ Lanham JG, Elkon KB, Pusey CD, Hughes GR (1984). "Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome". Medicine (Baltimore). 63 (2): 65–81. PMID 6366453.